• Bolt Biotherapeutics set its 2026 annual stockholder meeting for June 10, 2026, to be held online.
• Shareholders will vote on election of two Class II directors to terms running through 2029.
• Ballot also includes ratification of PricewaterhouseCoopers as independent registered public accounting firm for fiscal 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bolt Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-186923), on April 28, 2026, and is solely responsible for the information contained therein.